Home/Filings/4/0001127602-23-006965
4//SEC Filing

Price Andrew L 4

Accession 0001127602-23-006965

CIK 0000785161other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 12:07 PM ET

Size

6.3 KB

Accession

0001127602-23-006965

Insider Transaction Report

Form 4
Period: 2023-02-23
Price Andrew L
Interim Chief Accting Officer
Transactions
  • Award

    Encompass Health Common Stock

    2023-02-23+4,38870,450 total
  • Award

    Encompass Health Common Stock

    2023-02-23+2,72673,176 total
Footnotes (2)
  • [F1]This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 24, 2021.
  • [F2]Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

Issuer

Encompass Health Corp

CIK 0000785161

Entity typeother

Related Parties

1
  • filerCIK 0001475399

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 12:07 PM ET
Size
6.3 KB